Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocofersolan for Refractory Vitamin E Deficiency in Children
NCT03582384Phase 2Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of tocofersolan in Vitamin E deficiency, sponsored by Boston Children's Hospital. Planned start Dec 2020; status: withdrawn.
02
Drugs
tocofersolan
03
Conditions
Vitamin E deficiency
Beyond the preview
Go deeper on NCT03582384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582384.